Par Drugs IPO vs White Organic Retail IPO

Comparison between Par Drugs IPO and White Organic Retail IPO.

IPO Details

Par Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while White Organic Retail IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Par Drugs IPO is up to ₹8.10 Cr whereas the issue size of the White Organic Retail IPO is up to ₹14.68 Cr. The final issue price of Par Drugs IPO is ₹51.00 per share and of White Organic Retail IPO is ₹63.00 per share.

 Par Drugs IPOWhite Organic Retail IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹51.00 per share₹63.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size2000 shares2000 shares
Fresh Issue Size15,88,000 shares23,30,000 shares
Fresh Issue Size (Amount)up to ₹8.10 Crup to ₹14.68 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total15,88,000 shares23,30,000 shares
Issue Size Total (Amount)up to ₹8.10 Crup to ₹14.68 Cr

IPO Timetable

Par Drugs IPO opens on May 03, 2019, while White Organic Retail IPO opens on Apr 26, 2019. The closing date of Par Drugs IPO and White Organic Retail IPO is May 08, 2019, and May 02, 2019, respectively.

 Par Drugs IPOWhite Organic Retail IPO
Issue OpenMay 03, 2019Apr 26, 2019
Issue CloseMay 08, 2019May 02, 2019
Basis Of Allotment (Tentative)May 13, 2019May 07, 2019
Initiation of Refunds (Tentative)May 14, 2019May 08, 2019
Credit of Share (Tentative)May 15, 2019May 09, 2019
Listing date (Tentative)May 16, 2019May 10, 2019

Financials & KPIs

Par Drugs IPO P/E ratio is , as compared to White Organic Retail IPO P/E ratio of .

 Par Drugs IPOWhite Organic Retail IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Mar 201931 Mar 201831 Mar 2017
Assets51.3653.9456.04
Total Income46.4142.4248.81
Profit After Tax2.421.501.85
EBITDA5.288.028.50
NET Worth29.1220.7019.20
Reserves and Surplus24.6412.2510.75
Total Borrowing11.5823.1324.81
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Dec 201831 Mar 201831 Mar 201731 Mar 2016
Assets60.2350.1714.4812.77
Total Income116.3584.002.551.07
Profit After Tax4.513.020.590.24
EBITDA6.254.380.860.35
NET Worth0.000.000.000.00
Reserves and Surplus20.374.481.460.87
Total Borrowing0.000.000.000.00
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)99.55%100%
Promoter Shareholding (Post-Issue)72.5%55.01%
Market Cap₹31.38 Cr.₹34.36 Cr.

Shares Offered

In the Par Drugs IPO Retail Individual Investors (RII) are offered 7,80,000 shares while in White Organic Retail IPO retail investors are offered 7,80,000 shares. Qualified Institutional Buyers (QIB) are offered in Par Drugs IPO and in White Organic Retail IPO.

 Par Drugs IPOWhite Organic Retail IPO
Market Maker Reservation84,000 shares1,24,000 shares
NII7,78,000 shares11,64,000 shares
RII7,80,000 shares11,66,000 shares
Employee30,000 shares
Total15,88,000 shares23,30,000 shares

Bids Received (Subscription)

Par Drugs IPO subscribed 5.64x in total, whereas White Organic Retail IPO subscribed 1.36x.

 Par Drugs IPOWhite Organic Retail IPO
NII (times)3.48x2.03x
RII (times)7.97x0.70x
Employee (times)1.00x
Total (times)5.64x1.36x

Compare with others

Compare:

Par Drugs IPO Vs White Organic Retail IPO